ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Dermatitis
Atopic Dermatitis
Skin Diseases
Dyssomnias
Food Hypersensitivity
Hypersensitivity
Parasomnias

Eczema trials near Durham, NC, USA:

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial (DISCOVER)

The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis. Atopic dermatitis, also referred to as eczema...

Active, not recruiting
Atopic Eczema
Moderate-to-Severe Atopic Dermatitis
Other: Topical emollient (moisturizer)
Drug: dupilumab

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Durham, North Carolina, United States and 29 other locations

This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety...

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Placebo
Drug: Camoteskimab

Phase 2

Apollo Therapeutics

Raleigh, North Carolina, United States and 27 other locations

Global Assessment for Atopic Dermatitis (vIGA-AD).* Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema...

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

Phase 3

Amgen
Amgen

Durham, North Carolina, United States and 196 other locations

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Phase 3

Pfizer
Pfizer

Cary, North Carolina, United States and 557 other locations

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Phase 3

Lilly
Lilly

Raleigh, North Carolina, United States and 320 other locations

The study is a multicenter clinical trial and is designed as a proof-of-concept study to evaluate the efficacy, safety, tolerability, PK, immunogenic...

Enrolling
Atopic Dermatitis
Drug: BSI-045B
Drug: Dupilumab

Phase 2

Biosion

Cary, North Carolina, United States and 16 other locations

The purpose of this trial is to test different doses of the trial medicine (LEO 138559) at treating moderate to severe atopic dermatitis in adults. T...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: LEO 138559

Phase 2

LEO Pharma
LEO Pharma

Raleigh, North Carolina, United States and 72 other locations

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...

Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo

Phase 3

Amgen
Amgen

Durham, North Carolina, United States and 228 other locations

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Active, not recruiting
Moderate-to-Severe Atopic Dermatitis
Drug: Nemolizumab

Phase 3

Galderma
Galderma

Durham, North Carolina, United States and 342 other locations

The purpose of this extension trial is to evaluate the long-term safety of tralokinumab.

Active, not recruiting
Atopic Dermatitis
Drug: Tralokinumab

Phase 3

LEO Pharma
LEO Pharma

Raleigh, North Carolina, United States and 308 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems